Abstract
Non-insulin-dependent diabetes mellitus (NIDDM) is a hereditary, chronic disease which is characterized by hyperglycemia. In most patients with manifest NIDDM, signs of hormonal dysbalance as well as insulin resistance are evident (1,2). Of the hormonal disturbances, impaired glucose-stimulated insulin response from the B-cells stands out as the most important defect (1,3). However, altered A- and D-cell secretion of glucagon and somatostatin, respectively, may also contribute to the diabetic state. Thus, the glucagon response to amino acids given i.v. and mixed meal is exaggerated and the suppressi-bility of glucagon release by glucose administered orally or i.v. is reduced (4,5). As in case of insulin release, glucose-induced somatostatin release is impaired or abolished (6). Since normalization of blood glucose levels by insulin infusion restored somatostatin response in NIDDM patients (7), the defect in D-cell function appears secondary to hyperglycemia and/or hypoinsulinemia. The mechanisms behind the altered A-cell response in NIDDM are more complex. Thus, after normalization of glycemia in artificial pancreas normal glucagon responses were found when patients were given intravenous arginine (8) and glucose (9). Conversely, even after normalization of glucose control in artificial pancreas, a mixed meal induced an exaggerated glucagon response, while oral glucose failed to suppress glucagon levels (7). Interestingly, in patients with insulin-dependent diabetes mellitus treatment with artificial pancreas normalized glucagon responses irrespective whether glucose or amino acids were given i.v. or orally (10, 11).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. Efendic, R. Luft, and A. Wajngot, Aspects of the pathogenesis of type 2 diabetes, Endocr. Rev. 5:395–409 (1984).
R.A. DeFronzo, R.C. Bonadonna, and E. Ferrannini, Pathogenesis of NIDDM. A balanced overview, Diabetes Care 15:317–368 (1992).
S. Efendic, V. Grill, R. Luft, and A. Wajngot, Low insulin response: a marker of prediabetes. Adv. Exp. Med. Biol. 246:167–174 (1988).
R.H. Unger, E. Aquilar-Parada, W.A. Müller, and A.M. Eisentraut, Studies of pancreatic alpha cell function in normal and diabetic subjects, J. Clin. Invest. 49:837–848 (1970).
S. Efendic, M. Gutniak, and V. Grill, Hormonal release in NIDDM, in: “Pathogenesis of Non-Insulin Dependent Diabetes Mellitus”, V. Grill, and S. Efendic, eds, Raven Press, New York, pp. 271–284 (1988).
V. Grill, M. Gutniak, A. Roovete, and S. Efendic, A stimulating effect of glucose on somatostatin release is impaired in non-insulin-dependent diabetes mellitus, J. Clin. Endocrinol. Metab. 59:293–297 (1984).
M. Gutniak, V. Grill, and S. Efendic, Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: Evidence for more than one mechanism of action, J. Clin. Endocrinol. Metab. 62:77–83 (1986).
R. Kawamori, M. Shichiri, Y. Yamasaki, and H. Abe, Perfect normalization of excessive glucagon response to intravenous arginine in human diabetes mellitus with the artificial beta cell, Diabetes 29:762–765 (1980).
P. Raskin, Y. Fujita, and R.H. Unger, Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and non-diabetics, J. Clin. Invest. 56:1132–1138 (1975).
M. Gutniak, V. Grill, K.-L. Wiechel, and S. Efendic, Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization, Diabetes 36:802–807 (1987).
M. Gutniak, V. Grill, A. Roovete, and S. Efendic, Impaired somatostatin response to orally administered glucose in NIDDM patients entails both somatostatin-28 and-14 and is associated with deranged metabolic control, Acta Endocrinol 121:322–326 (1989).
S.J. Lillioja, B.L. Nyomba, M.F. Saad, R. Ferraro, C. Castillo, P.H. Bennett, and C. Bogardus, Exaggerated early insulin release and insulin resistance in a diabetes prone population: a metabolic comparison of Pima Indians and Caucasians, J. Clin. Endocrinol. Metab. 73:866–876 (1991).
G.M. Reaven, Banting Lecture. Role of insulin resistance in human disease, Diabetes 37:1595–1607 (1988).
R. Luft, E. Cerasi, and B. Andersson, Obesity as an additional factor in the pathogenesis of diabetes, Acta Endocrinol. (Copenh.) 59:344–352 (1968).
R. Luft, E. Cerasi, and C.A. Hamberger, Studies on the pathogenesis of diabetes in acromegaly, Acta Endocrinol (Copenh.) 56:593–607 (1967).
K. Kimura, T. Toyota, M. Kakisaki, M. Kudo, K. Takebe, and Y. Goto, Impaired insulin secretion in the spontaneous diabetic rats, Tohoku J. Exp. Med. 137:453–459 (1982).
Y. Goto, K. Suzuki, M. Sasaki, T. Ono, and S. Abe, GK rat as a model of nonbese, noninsulin-dependent diabetes, in: “Frontiers in Diabetes Research. Lessons from Animal Diabetes II”, E. Shafrir, and A.E. Renold, eds, John Libbey, London, pp. 301–303 (1988).
B. Portha, P. Serradas, D. Bailbe, K. Suzuki, Y. Goto, and M.-H. Giroix, ß-Cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes, Diabetes 40:486–491 (1991).
C.-G. Östenson, A. Khan, S.M. Abdel-Halim, A. Guenifi, K. Suzuki, Y. Goto, and S. Efendic, Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat, Diabetologia 36:3–8 (1993).
K. Suzuki, Y. Goto, and T. Toyota, Spontaneously diabetic GK (Goto-Kakizaki) rats, in: “Frontiers in Diabetes Research. Lessons from Animal Diabetes IV”, E. Shafrir, ed, Smith-Gordon, London, pp. 107–116 (1992).
C.-G. Östenson, S.M. Abdel-Halim, V. Grill, A. Guenifi, P. Jalkanen, M. Sundén, and S. Efendic, Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats, Diabetologia 34(Suppl. 2):A76 (1991).
B. Portha, D. Bailbe, P. Serradas, O. Blondel, and M.-H. Giroix, Insulin resistance in the GK rat, a spontaneous non obese model for non-insulin-dependent diabetes, Diabetologia 33:A229 (1990).
Y. Goto, M. Kakizaki, and S. Yagihashi, Neurological findings in spontaneously diabetic rats, Excerpta Medica ICS, No. 581:26–38 (1982).
K. Suzuki, Y.-C. Hsiao, T. Toyota, el al., The significance of nerve sugar levels for the peripheral nerve impairment of spontaneously diabetic (Goto-Kakizaki) rats. Diabetes Res. 14:21–25 (1990).
B. Hellman, C. Berne, E. Grapengiesser, V. Grill, E. Gylfe, and P.-E. Lund, The cytoplasmic Ca2+ response to glucose as an indicator of impairment of the pancreatic ß-cell function, Europ. J. Clin. Invest. 20:S10–S17 (1990).
A. Marcström, P.-E. Lund, and B. Hellman, Regulatory volume decrease of pancreatic ß-cells involving activation of tetraethylammonium-sensitive K+ conductance, Mol. Cell. Biochem. 96:35–41 (1990).
W.J. Malaisse, J.C. Hutton, S. Kawazu, A. Herchuelz, I. Valverde, and A. Sener, The stimulus-secretion coupling of glucose-induced insulin release. XXXV. The links between metabolic and cationic events, Diabetologia 16:331–341 (1979).
P. Arkhammar, T. Nilsson, P. Rorsman, and P.-O. Berggren, Inhibition of ATP-regulated K+ channels precedes depolarization-induced increase in cytoplasmic free Ca2+ concentration in pancreatic ß-cells, J. Biol. Chem. 262:5448–5454 (1987).
P.A. Halban, S. Bonner-Weir, and G.C. Weir, Elevated proinsulin biosynthesis in vitro from a rat model of non-insulin-dependent diabetes mellitus, Diabetes 32:277–281 (1983).
V. Grill, and C.-G. Östenson, The influence of a diabetic state on insulin secretion: studies in animal models of non-insulin dependent diabetes, in: “Pathogenesis of Non-Insulin Dependent Diabetes Mellitus”, V. Grill, and S. Efendic, eds, Raven Press, New York, pp. 93–106 (1988).
S.M. Abdel-Halim, A. Guenifi, S. Efendic, and C.-G. Östenson, Both somatostatin and insulin responses to glucose are impaired in the perfused pancreas of the spontaneously non-insulin-dependent diabetic GK (Goto-Kakizaki) rats, Acta Physiol. Scand., in press.
L.A. Nolte, I.K. Martin, S.M. Abdel-Halim, A. Guenifi, C.-G. Östenson, and H. Wallberg-Henriksson, Effect of elevated blood glucose on insulin-stimulated glucose transport in rat muscle, Diabetologia 35(Suppl. 1):A80 (1992).
S. Westman, Development of the obese-hyperglycemic syndrome in mice, Diabetologia 4:141–149 (1968).
A. Khan, C.-G. Östenson, P.-O. Berggren, and S. Efendic, Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice, Am. J. Physiol. 263:E663–E666 (1992).
B. Ahrén, C.-G. Östenson, and S. Efendic, Other islet peptides, in: “The Endocrine Pancreas”, E. Samols, ed, Raven Press, New York, pp. 153–173 (1991).
P.-O. Berggren, P. Rorsman, S. Efendic, C.-G. Östenson, P. Flatt, T. Nilsson, P. Arkhammar, and L. Juntti-Berggren, Mechanisms of action of entero-insular hormones, islet peptides and neural input on the insulin secretory process, in: “Nutrient Regulation of Insulin Secretion”, P. Flatt, ed, Portland Press, London, pp. 289–318 (1992).
J.H. Johnson, C.B. Newgard, J.L. Milburn, H.F. Lodish, and B. Thorens, The high K glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence, J. Biol. Chem 265:6548–6551 (1990).
L. Orci, B. Thorens, M. Ravazzola, and H.F. Lodish, Localization of the pancreatic beta cell glucose transporter to specific plasma membrane domains, Science 245:295–297 (1990).
M.D. Meglasson, and F.M. Matschinsky, New perspectives on pancreatic islet glucokinase, Am. J. Physiol. 246:E1–13 (1984).
S. Efendic, H. Kindmark, and P.-O. Berggren, Mechanisms involved in the regulation of the insulin secretory process, J. Internal Med. 229(Suppl. 2):9–22 (1991).
A. Khan, V. Chandramouli, C.-G. Östenson, H. LÖw, B.R. Landau, and S. Efendic, Glucose cycling in islets from healthy and diabetic rats, Diabetes 39:456–459 (1990).
B. Portha, M.-H. Giroix, P. Serradas, N. Welsh, C. Hellerström, A. Sener, and W.J. Malaisse, Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM, Diabetes 37:1226–1233 (1988).
J. Katz, and R. Rognstad, Futile cycles in the metabolism of glucose, Curr. Top. Cell. Regul. 10:237–289 (1976).
I.-B. Täljedal, Presence, induction and possible role of glucose-6-phosphatase in mammalian pancreatic islets, Biochem. J. 114:387–394 (1969).
A. Khan, V. Chandramouli, C.-G. Östenson, B. Ahrén, W.C. Schumann, H. Löw, B.R. Landau, and S. Efendic, Evidence for the presence of glucose cycling in pancreatic islets of ob/ob mouse, J. Biol. Chem. 264:9732–9733 (1989)
R. Anjaneyulu, K. Anjaneyulu, A.R. Carpinelli, A. Sener, and W.J. Malaisse, The stimulus secretion coupling of glucose-induced insulin release: enzymes of man-nose metabolism in pancreatic islets, Arch. Biochem. Biophys. 212:54–62 (1981).
A. Khan, V. Chandramouli, C.-G. Östenson, P.-O. Berggren, H. Löw, B.R. Landau, and S. Efendic, Glucose cycling is markedly enhanced in pancreatic islets of obese hyperglycemic mice, Endocrinology 126:2413–2416 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Östenson, CG., Khan, A., Efendic, S. (1993). Impaired Glucose-Induced Insulin Secretion: Studies in Animal Models with Spontaneous NIDDM. In: Östenson, C.G., Efendić, S., Vranic, M. (eds) New Concepts in the Pathogenesis of NIDDM. Advances in Experimental Medicine and Biology, vol 334. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2910-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2910-1_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6262-3
Online ISBN: 978-1-4615-2910-1
eBook Packages: Springer Book Archive